Reproductive and developmental toxicity evaluation of a purified Arabinogalactan-Protein (AGP) composition in Wistar rats

Fitoterapia

Volumn 81, Issue 4, 2010, Pages 276-283

  Tamboli, Salim ^a   Arora, Sudershan ^a   Bhatnagar, Upendra ^a   Vishwase, Gururaj ^a   Singh, Minakshi ^a  

^a LUPIN LIMITED   (India)

Author keywords

Arabinogalactan Protein; Argemone mexicana; Developmental toxicity; LL 4218; Psoriasis; Reproductive toxicity

Indexed keywords

ARABINOGALACTAN; LL 4218; UNCLASSIFIED DRUG; GALACTAN; PLANT EXTRACT; VEGETABLE PROTEIN;

ANIMAL EXPERIMENT; ARGEMONE MEXICANA; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG ISOLATION; DRUG SAFETY; FEMALE; FEMALE FERTILITY; MALE; MALE FERTILITY; MAXIMUM TOLERATED DOSE; NONHUMAN; PLANT LEAF; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PSORIASIS; RAT; REPRODUCTION; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SKELETON MALFORMATION; TOXICITY TESTING; VISCERA; WISTAR RAT; ANIMAL; ARGEMONE; CHEMISTRY; DRUG EFFECTS; FERTILITY; FETUS DEVELOPMENT; ISOLATION AND PURIFICATION; PREGNANCY; TOXICITY;

ANIMALS; ARGEMONE; FEMALE; FERTILITY; FETAL DEVELOPMENT; GALACTANS; MALE; PLANT EXTRACTS; PLANT PROTEINS; PREGNANCY; RATS; RATS, WISTAR;

ARGEMONE MEXICANA; RATTUS; RATTUS NORVEGICUS;

EID: 77950627243     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2009.10.001     Document Type: Article

References (23)

1. Classen B., Witthohn K., and Blaschek W. Carbohydr Res 327 (2000) 497-504
2. Gane M.A., Craik D., Munro S.L.A., Howlett G.J., Clarke A.E., and Bacic A. Carbohydr Res 277 (1995) 67-85
3. Duan J., Wang X., Dang Q., Fang J., and Li X. Carbohydr Res 338 (2003) 1291-1297
4. Anderson R.L., Clarke A.E., Jermyn M.A., Knox R.B., and Stone B.A. Aust J Plant Physiol 4 (1977) 143-158
5. Hawes G.B., and Adams G.A. Phytochemisrty 11 (1972) 1461-1465
6. Peter D'adamo N.D. J Naturopath Med 4 (1996) 32-39
7. Wagner H. Bundesrepublik Deutsches Patentamet DE 3042491 7/15/82.
8. Reith FJ. Bundesrepublik Deutsches Patentamet 27 21 014 11/16/78.
9. Code of Federal Regulations, Title 21, 1974.
10. Arora SK, Srivastava V, Walunj SS. U.S. Patent Application Publication No. 2003/0194456 Al.
11. Schedule "Y" in Drug and Cosmetics (Revised) Rule 2005, Ministry of Health and Family Welfare, Govt. of India.
12. ICH Harmonized Tripartite Guideline. "Detection of toxicity to reproduction for medicinal products". ICH-S5A, June 1994.
13. Clegg E.D., Perreault S.D., and Klinefelter G.R. Assessment of male reproductive Toxicity. In: Hayes (Ed). Principles and methods of toxicology. Edition 4 (2001) 1263-1300
14. Russell L.D., Ettlin R.A., Hikim A.P.S., and Clegg E.D. Int J Androl 16 (1993) 83
15. Salewski E. Arch. Exp Pathol Pharmakol 247 (1964) 367
16. Staples R.E. Teratology 9 (1974) A-37
17. Wilson J.G. Teratology principles and techniques (1965), University of Chicago Press 262-277
18. Dawson A.B. Biotech Histochem 1 (1926) 123-124
19. Narotsky M.G., and Rogers J.M. Developmental biology protocols vol. 1 (2000), Humana Press, New Jersey 139-150
20. Snedecor G.W., and Cochran W.G. Statistical methods. 6th edition (1967), Iowa State University Press, Ames, IA
21. Steven F. Dermatol Online J 6 1 (2000) 4
22. Raza M., Al Shabanah O.A., El-Hadiyah T.M., and Al-Majed A.A. Sci Pharm 70 (2002) 135-145
23. MARTA and MTA. Historical control data (1992-1994) for developmental and reproductive toxicity studies using the Crl:SD (SD) BR rat. Charles Rivers Laboratories, March 1996.